tlooto
Sign up
Health Systems, Economic Evaluations, Quality of LifePrimary Care and Health OutcomesHealthcare Policy and Management

Valuing Public Sector Data Assets: Methodological Perspectives from the Add-Aspirin Trial's Use of Healthcare Systems Data for Clinical Follow-up

Kang Shu, Meng-Chin Cheng

2026.4.1CLINICAL ONCOLOGY

DOI: 10.1016/j.clon.2026.104162

Abstract

Abstract is not available.

Citation format

SHU, Kang; CHENG, Meng-Chin. Valuing public sector data assets: Methodological perspectives from the add-aspirin trial's use of healthcare systems data for clinical follow-up. CLINICAL ONCOLOGY, 2026, 56: 104162.